drugset / Trial / NCT02694146

Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis

NCT02694146

Phase 3 Completed 74 enrolled Fundación Pública Andaluza Progreso y Salud
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy and safety of platelet rich plasma (PRP) in patients with coxarthrosis who don´t respond to treatment with NSAIDs, compared to treatment with hyaluronic acid (Hylan G-F 20).

Timeline

Start
2016-03
Primary completion
2018-05
Completion
2018-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hylan G-F 20 Other / unclassified 6 ml Other
Comparator Hylan G-F 20 Other / unclassified 60 mg Other
Subject Platelet Rich Plasma Other / unclassified 6 ml Other

Indications